Biodexa Pharmaceuticals Files 2024 Annual Report
Ticker: BDRX · Form: 6-K · Filed: May 23, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Biodexa dropped its 2024 annual report on 5/23/25. Check financials.
AI Summary
Biodexa Pharmaceuticals PLC filed its annual report for the year ended December 31, 2024, on May 23, 2025. The company, formerly known as Midatech Pharma Plc, is based in Cardiff, United Kingdom, and operates in the pharmaceutical preparations industry. This filing is made under the 1934 Act.
Why It Matters
This filing provides investors with the company's financial performance and operational highlights for the fiscal year 2024, enabling them to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material events or significant financial changes.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Filer of the report
- Midatech Pharma Plc (company) — Former company name
- May 23, 2025 (date) — Filing date of the report
- December 31, 2024 (date) — Fiscal year end date
- 001-37652 (other) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed by Biodexa Pharmaceuticals PLC to report its Annual Report for the year ended December 31, 2024.
When was the annual report filed?
The annual report was posted on May 23, 2025.
What is Biodexa Pharmaceuticals PLC's former name?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc.
Where is Biodexa Pharmaceuticals PLC located?
The company's principal executive offices are located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Under which SEC Act is this filing made?
This filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).